Saltar al contenido
Merck

Novel spirocyclic pyrrolidones as P2/P1 mimetics in potent inhibitors of HIV-1 protease.

Bioorganic & medicinal chemistry letters (2002-11-07)
Wieslaw M Kazmierski, Eric Furfine, Andrew Spaltenstein, Lois L Wright
RESUMEN

We have developed concise and efficient syntheses of novel spirocyclic pyrrolidones 1-3, which involve the alkylation of pyrrolidone precursor 13 with 1,5-dibromopentane, 16 and 15, followed by an in situ lactamization. Conjugates of 1 and 2 with P1'/P2' hydroxy-indanolamine moiety resulted in novel and potent inhibitors of HIV-1 protease 25 and 26, suggesting that 1 and 2 are novel P2/P1 HIV-PI mimetics.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
1,5-Dibromopentane, 97%